| fluticasone propionate inhalation powder / Generic mfg. |
ANASSA-PD, NCT04665895 / 2020-002977-84: A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma |
|
|
| Completed | 3 | 451 | Europe | Fluticasone propionate 100 mcg/blister oral inhalation powder/Respirent Pharmaceuticals, FLOVENT DISKUS® 100 mcg/blister oral inhalation powder/GSK, FLOVENT, Placebo | Respirent Pharmaceuticals Co Ltd., Becro Ltd. | Asthma | 08/21 | 02/22 | | |
NCT05021887: A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions |
|
|
| Recruiting | 1 | 50 | Europe | Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals, Test, FLOVENT DISKUS, Reference | Respirent Pharmaceuticals Co Ltd., Becro Ltd. | Asthma, Bioequivalence | 09/21 | 11/21 | | |
NCT05397834: A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 250 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions |
|
|
| Active, not recruiting | 1 | 36 | Europe | Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals, Test, FLOVENT DISKUS, Reference | Respirent Pharmaceuticals Co Ltd., Becro Ltd. | Asthma, Bioequivalence | 06/22 | 09/22 | | |